Bio Pharma Dive
OCTOBER 28, 2021
Executives based their projections on contracts already in place for the drug, known as molnupiravir. But sales could climb even higher if it works as a preventive treatment too.
Pharma Mirror
OCTOBER 28, 2021
Amsterdam, The second part of the 2021 CPhI Annual Report looks ahead to predict the pharma manufacturing, therapeutic and technology environment in 2030. The analysis foresees the use of automated cobots, AI, real-time release and rapid growth in new areas like mRNA vaccines, alongside the personalization of therapeutics (delivered at far larger scale).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
OCTOBER 28, 2021
In a move that surprised Wall Street analysts, the executive, who has overseen Alnylam's journey from startup to one of biotech's top companies, will leave by the end of the year for an unspecified role "helping other entrepreneurs.
pharmaphorum
OCTOBER 28, 2021
Groups representing the biopharma industry have welcomed an increase in health-specific R&D to £5 billion in the UK autumn budget, despite a longer timeline for reaching the target of £22 billion in overall R&D spending. The Association of the British Pharmaceutical Industry (ABPI) and BioIndustry Association (BIA) both said that the increase acknowledges the enormous contribution made by the life sciences sector in helping to limit the impact of the pandemic through the rapid developmen
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Bio Pharma Dive
OCTOBER 28, 2021
The two institutions will work with drugmakers and non-profit groups on a wide-ranging initiative meant to make the complex treatments easier and less costly produce.
BioSpace
OCTOBER 28, 2021
?The 174,000 square-foot location will house a fully-equipped production plant to create its initial programs for Type 1 diabetes, a specific genetic cause of autism, galactosemia, and more.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
XTalks
OCTOBER 28, 2021
BioNTech has announced plans to build a manufacturing facility in Africa to help ramp up production of COVID-19 mRNA vaccines for countries in the continent. On Tuesday, the German biotech company inked a deal with Rwanda’s government and Institut Pasteur de Dakar in Senegal to begin construction of the facility in mid-2022. With less than ten percent of its population vaccinated, Africa continues to be deeply affected by global vaccine inequities.
pharmaphorum
OCTOBER 28, 2021
Japanese drugmaker Takeda has said it will exercise its option to buy UK-based GammaDelta Therapeutics, a specialist in ‘off-the-shelf’ cell therapies for solid tumours and blood cancers. The two companies have been working together since 2017, with Takeda pledging $100 million to help GammaDelta advance its cell therapy platform as part of a “build-to-buy” arrangement.
XTalks
OCTOBER 28, 2021
The National Confectioners Association (NCA) reported that Halloween candy sales have increased in 2021 compared to 2020. Retailers have 27 percent more seasonal items this year than last year, and 93 percent of consumers are looking forward to ways they are going to celebrate this day. In fact, sales of chocolate and candy are up 48 percent compared to 2020, and nearly 60 percent since 2019. “Chocolate and candy sales have come roaring back during the 2021 Halloween season as excitement
Triage Cancer
OCTOBER 28, 2021
As more employers require their employees to get vaccinated, the federal government’s requirement for larger employers to have vaccine mandates moves forward, and schools are considering vaccine requirements for students, you might be wondering: are COVID-19 vaccine mandates legal? The Centers for Disease Control & Prevention (CDC) has indicated that COVID-19 vaccines are safe and effective.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
XTalks
OCTOBER 28, 2021
California-based The Urgent Company recently unveiled a plant-based, climate-friendly cake mix under the company’s Brave Robot brand. Packaged in a compostable bag, the Climate Hero Super Cake is a versatile, shelf-stable yellow cake mix that requires adding only oil and water. So, how does Brave Robot’s new cake mix differ from the rest? First, while most cake mixes require eggs for structure, color and flavor, the Climate Hero Super Cake mix replaces approximately three eggs with the use of fo
pharmaphorum
OCTOBER 28, 2021
Combining decades of healthcare, life sciences and collaborative research to transform the way care is delivered. Kansas City, Mo. — Oct. 26, 2021 — Cerner Corporation (NASDAQ: CERN), a global healthcare technology company, announces the launch of a new operating unit, Cerner Enviza SM , that offers data-driven solutions and research services to help bring clarity to multi-dimensional data through real-world evidence and insights.
BioSpace
OCTOBER 28, 2021
In the face of Delta, the actual efficacy of the vaccines has come into question, while global cases and deaths from COVID-19 increased for the first time in two months, primarily in Europe.
pharmaphorum
OCTOBER 28, 2021
A generic pill has been shown to reduce hospitalisation rates in high-risk patients with early COVID-19, potentially offering a low-cost alternative to oral antivirals from Merck & Co and others, according to researchers in Brazil. The antidepressant fluvoxamine given as a twice-daily regimen for 10 days to acutely symptomatic patients with COVID-19 who also had at least one risk factor such as diabetes, cardiovascular disease, underlying respiratory conditions such as chronic asthma and obe
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
BioSpace
OCTOBER 28, 2021
After first reporting that its investigational RNAi drug vutrisiran hit its 9-month Phase III endpoints, Alnylam announced it continues to demonstrate positive results at the 18-month mark.
Scienmag
OCTOBER 28, 2021
Growing up in Pennsylvania as the daughter of a casket salesman, UMass Lowell’s Bridget Marshall, associate professor of English, became more familiar with death than most children. Credit: Katharine Webster Growing up in Pennsylvania as the daughter of a casket salesman, UMass Lowell’s Bridget Marshall, associate professor of English, became more familiar with death than […].
BioSpace
OCTOBER 28, 2021
Digital interdisciplinary journal Science Translational Medicine published a new study this week that proposed a potential new biomarker for predetermining patient responsiveness to ICB therapies.
Scienmag
OCTOBER 28, 2021
CORVALLIS, Ore. – Oregon State University researchers and a team of West Coast university collaborators have received a $7.65 million grant to study the impact of smoke exposure on grapes, a project that will provide critical knowledge to grape growers and winery owners severely impacted by widespread wildfire smoke in recent years. Credit: Sean Nealon […].
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
BioSpace
OCTOBER 28, 2021
Kymera was able to demonstrate for the first time proof-of-biology ex vivo using whole blood from one of their KT-474 treated patient cohorts.
Scienmag
OCTOBER 28, 2021
A team of researchers, led by Domenico Giustiniano, Research Associate Professor at IMDEA Networks Institute, Madrid, has presented important advances in the creation of sustainable wireless communication systems. This represents a new step towards making battery-free devices a reality, through the convergence of two emerging technologies: LiFi and radio frequency (RF) backscatter.
BioSpace
OCTOBER 28, 2021
Gilead Sciences has one of the most robust HIV pipelines in the world. New real-world data from the ongoing BICSTaR study demonstrates benefits of HIV drug Biktarvy.
Scienmag
OCTOBER 28, 2021
Recent advances on materials in development since the 1980’s at Osaka Prefecture University (OPU) bring all-solid-state batteries (ASSBs) a step closer towards reality. Credit: A. Sakuda, OSAKA PREFECTURE UNIVERSITY Recent advances on materials in development since the 1980’s at Osaka Prefecture University (OPU) bring all-solid-state batteries (ASSBs) a step closer towards reality.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
BioSpace
OCTOBER 28, 2021
Albert Bourla, chief executive officer of Pfizer, argued this week that politicians were approaching the problem of drug pricing the wrong way — as usual.
Scienmag
OCTOBER 28, 2021
In a dry year in the West, when the world turns crispy and cracked, rivers and streams with their green, lush banks become a lifesaving yet limited resource. Credit: Monte Neate-Clegg In a dry year in the West, when the world turns crispy and cracked, rivers and streams with their green, lush banks become a […].
BioSpace
OCTOBER 28, 2021
The U.S. Food and Drug Administration granted Emergency Use Authorization (EUA) for the Pfizer-BioNTech vaccine for children ages 5 to 11.
Scienmag
OCTOBER 28, 2021
From the Florida Keys to the Caribbean Sea, coral reefs, the complex ecosystems that house 25% of marine species, are dying from a novel infection known as stony coral tissue loss disease (SCTLD). Credit: Randy Gentry/UTA From the Florida Keys to the Caribbean Sea, coral reefs, the complex ecosystems that house 25% of marine species, […].
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
BioSpace
OCTOBER 28, 2021
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
Scienmag
OCTOBER 28, 2021
Plastics have taken the world by storm over the last century, finding applications in virtually every aspect of our lives. However, the rise of these synthetic polymers, which form the basis of plastics, has contributed to many serious environmental issues. The worst of these is the excessive use of petrochemical compounds and the disposal of […].
Pharma Times
OCTOBER 28, 2021
The FDA will likely make a formal decision on the use of the vaccine in this age group in the coming days
Scienmag
OCTOBER 28, 2021
Rodrigo Augusto Dos Santos, a doctoral candidate in the Computer Science and Engineering Department at The University of Texas at Arlington, is one of 10 students nationwide to win a Computing Alliance of Hispanic-Serving Institutions (CAHSI) Google Dissertation Award. Credit: UT Arlington Rodrigo Augusto Dos Santos, a doctoral candidate in the Computer Science and Engineering […].
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
306 
Let's personalize your content